Radiation and hypoxia inducible gene therapy systems

Cancer and Metastasis Reviews

Volumn 23, Issue 3-4, 2004, Pages 269-276

  Scott, Simon D ^a   Greco, Olga ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Cre lox recombination; hypoxia; promoters; radiation; suicide gene; targeting

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

CANCER RADIOTHERAPY; EXPRESSION VECTOR; FEEDBACK SYSTEM; GENE AMPLIFICATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENE THERAPY; GENE VECTOR; GENETIC RECOMBINATION; HUMAN; HYPOXIA; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; REVIEW; SOLID TUMOR; SUICIDE GENE; TRANSGENE; TREATMENT OUTCOME;

ANIMALS; CELL HYPOXIA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; NEOPLASMS; OXYGEN;

EID: 3042736849     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CANC.0000031766.58614.f1     Document Type: Review

References (35)

1. Greco O, Dachs GU: Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives. J Cell Physiol 187: 22-36, 2001
2. Kim JH, Kim SH, Brown SL, Freytag SO: Selective enhancement by an antiviral agent of the radiation-induced cell killing of human glioma cells transduced with HSV-tk gene. Cancer Res 54: 6053-6056, 1994
3. Boothman DA, Lee IW, Sahijdak WM: Isolation of an x-ray-responsive element in the promoter region of tissue-type plasminogen-activator: Potential uses of x-ray-responsive elements for gene-therapy. Radiat Res 138: S68-S71, 1994
4. Marples B, Greco O, Joiner MC, Scott SD: Molecular approaches to chemo-radiotherapy. Eur J Cancer 38: 231-239, 2002
5. Gius D, Cao XM, Rauscher FJ, 3rd, Cohen DR, Curran T, Sukhatme VP: Transcriptional activation and repression by Fos are independent functions: The C terminus represses immediate-early gene expression via CArG elements. Mol Cell Biol 10: 4243-4255, 1990
6. Datta R, Rubin E, Sukhatme V, Qureshi S, Hallahan D, Weichselbaum RR, Kufe DW: Ionizing radiation activates transcription of the EGR1 gene via CArG elements. Proc Natl Acad Sci USA 89: 10149-10153, 1992
7. Weichselbaum RR, Hallahan DE, Beckett MA, Mauceri HJ, Lee H, Sukhatme VP, Kufe DW: Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. Cancer Res 54: 4266-4269, 1994
8. Hallahan DE, Mauceri HJ, Seung LP, Dunphy EJ, Wayne JD, Hanna NN, Toledano A, Hellman S, Kufe DW, Weichselbaum RR: Spatial and temporal control of gene therapy using ionizing radiation. Nat Med 1: 786-791, 1995
9. Joki T, Nakamura M, Ohno T: Activation of the radiosensitive EGR-1 promoter induces expression of the herpes simplex virus thymidine kinase gene and sensitivity of human glioma cells to ganciclovir. Hum Gene Ther 6: 1507-1513, 1995
10. Takahashi T, Namiki Y, Ohno T: Induction of the suicide HSV-TK gene by activation of the Egr-1 promoter with radioisotopes. Hum Gene Ther 8: 827-833, 1997
11. Manome Y, Kunieda T, Wen PY, Koga T, Kufe DW, Ohno T: Transgene expression in malignant glioma using a replication-defective adenoviral vector containing the Egr-1 promoter: Activation by ionizing radiation or uptake of radioactive iododeoxyuridine. Hum Gene Ther 9: 1409-1417, 1998
12. Quinones A, Dobberstein KU, Rainov NG: The egr-1 gene is induced by DNA-damaging agents and non-genotoxic drugs in both normal and neoplastic human cells. Life Sci 72: 2975-2992, 2003
13. Datta R, Taneja N, Sukhatme VP, Qureshi SA, Weichselbaum R, Kufe DW: Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci USA 90: 2419-2422, 1993
14. Meyer RG, Kupper JH, Kandolf R, Rodemann HP: Early growth response-1 gene (Egr-1 ) promoter induction by ionizing radiation in U87 malignant glioma cells in vitro. Eur J Biochem 269: 337-346, 2002
15. Sakamoto KM, Bardeleben C, Yates KE, Raines MA, Golde DW, Gasson JC: 5′ upstream sequence and genomic structure of the human primary response gene, EGR-1/TIS8. Oncogene 6: 867-871, 1991
16. Marples B, Scott SD, Hendry JH, Embleton MJ, Lashford LS, Margison GP: Development of synthetic promoters for radiation-mediated gene therapy. Gene Ther 7: 511-517, 2000
17. Scott SD, Joiner MC, Marples B: Optimizing radiation-responsive gene promoters for radiogenetic cancer therapy. Gene Ther 9: 1396-1402, 2002
18. Scott SD, Marples B, Hendry JH, Lashford LS, Embleton MJ, Hunter RD, Howell A, Margison GP: A radiation-controled molecular switch for use in gene therapy of cancer. Gene Ther 7: 1121-1125, 2000
19. Greco O, Marples B, Dachs GU, Williams KJ, Patterson AV, Scott SD: Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Ther 9: 1403-1411, 2002
20. Greco O, Marples B, Joiner MC, Scott SD: How to overcome (and exploit) tumor hypoxia for targeted gene therapy. J Cell Physiol 197: 312-325, 2003
21. Brown JM, Giaccia AJ: The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res 58: 1408-1416, 1998
22. Beck I, Weinmann R, Caro J: Characterization of hypoxia-responsive enhancer in the human erythropoietin gene shows presence of hypoxia-inducible 120-Kd nuclear DNA-binding protein in erythropoietin-producing and nonproducing cells. Blood 82: 704-711, 1993
23. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, Maxwell PH, Pugh CW, Ratcliffe PJ: Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292: 468-472, 2001
24. Greco O, Patterson AV, Dachs GU: Can gene therapy overcome the problem of hypoxia in radiotherapy? J Radiat Res (Tokyo) 41: 201-212, 2000
25. Marples B, Greco O, Joiner MC, Scott SD: Radiogenetic therapy: Strategies to overcome tumor resistance. Curr Pharm Des 9: 2105-2112, 2003
26. Nettelbeck DM, Jerome V, Muller R: A strategy for enhancing the transcriptional activity of weak cell type-specific promoters. Gene Ther 5: 1656-1664, 1998
27. Segawa T, Takebayashi H, Kakehi Y, Yoshida O, Narumiya S, Kakizuka A: Prostate-specific amplification of expanded polyglutamine expression: A novel approach for cancer gene therapy. Cancer Res 58: 2282-2287, 1998
28. A-Mohammadi S, Hawkins RE: Efficient transgene regulation from a single tetracycline-controled positive feedback regulatory system. Gene Ther 5: 76-84, 1998
29. Sternberg N, Hamilton D: Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol 150: 467-486, 1981
30. Sauer B, Henderson N: Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome. Nucleic Acids Res 17: 147-161, 1989
31. Lakso M, Sauer B, Mosinger B Jr., Lee EJ, Manning RW, Yu SH, Mulder KL, Westphal H: Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci USA 89: 6232-6236, 1992
32. Sakai K, Mitani K, Miyazaki J: Efficient regulation of gene expression by adenovirus vector-mediated delivery of the CRE recombinase. Biochem Biophys Res Commun 217: 393-401, 1995
33. Sato Y, Tanaka K, Lee G, Kanegae Y, Sakai Y, Kaneko S, Nakabayashi H, Tamaoki T, Saito I: Enhanced and specific gene expression via tissue-specific production of Cre recombinase using adenovirus vector. Biochem Biophys Res Commun 244: 455-462, 1998
34. Greco O, Marples B, Joiner MC, Scott SD: Gene therapy vectors activated by hypoxia and ionizing radiation. Proc Am Assoc Cancer Res 44: 1263, 2003
35. Greco O, Marples B, Joiner MC, Wilson GD, Scott SD: Cre/loxP-mediated 'molecular switch' vectors enhance the efficacy of hypoxia- and radiation-mediated cancer gene therapy in vitro and in vivo. Proc Am Assoc Cancer Res 45: 268, 2004